Results 231 to 240 of about 185,950 (370)

Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease

open access: bronze, 1995
Hiroyuki Takahashi   +9 more
openalex   +1 more source

Selatogrel: Potential to redefine timely anti‐platelet intervention

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 22, Page 5435-5452, November 2025.
Acute coronary syndrome (ACS) encompasses a number of heart diseases that cause a sudden decrease in coronary perfusion, precipitating cardiomyocyte necrosis or heightened risk thereof. This pathology is a major burden of cardiovascular disease.
Rudy N. Zalzal   +3 more
wiley   +1 more source

von Willebrand factor antigen levels in plasma of patients with malignant breast disease [PDF]

open access: gold, 2001
Liane Marise Röhsig   +5 more
openalex   +1 more source

State of the art: von Willebrand disease

open access: yesHaemophilia, 2016
Andra H. James   +2 more
semanticscholar   +1 more source

Type 2M and Type 2A von Willebrand Disease: Similar but Different

open access: yesSeminars in Thrombosis and Hemostasis, 2016
E. Favaloro, Leonardo Pasalic, J. Curnow
semanticscholar   +1 more source

Anti‐ADAMTS13 Antibodies Trajectory is Associated With ADAMTS13 Recovery in Immune‐Mediated TTP

open access: yesAmerican Journal of Hematology, Volume 100, Issue 10, Page 1736-1746, October 2025.
Anti‐ADAMTS13 IgG antibodies titer trajectory from baseline to day 7–14 post‐TPE as a reliable approach to identify iTTP patients at risk of late response to the triplet therapy regimen. ABSTRACT Current triplet regimens associating therapeutic plasma exchange (TPE), immunosuppression with corticosteroids and rituximab, and caplacizumab have ...
Marie Robert   +80 more
wiley   +1 more source

Home - About - Disclaimer - Privacy